These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30167449)

  • 1. A case of subungual tumors of incontinentia pigmenti: A rare manifestation and association with bipolar disease.
    Kibbi N; Totonchy M; Suozzi KC; Ko CJ; Odell ID
    JAAD Case Rep; 2018 Aug; 4(7):737-741. PubMed ID: 30167449
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of interaction between NEMO and SHARPIN impairs linear ubiquitination and NF-κB activation and leads to incontinentia pigmenti.
    Bal E; Laplantine E; Hamel Y; Dubosclard V; Boisson B; Pescatore A; Picard C; Hadj-Rabia S; Royer G; Steffann J; Bonnefont JP; Ursini VM; Vabres P; Munnich A; Casanova JL; Bodemer C; Weil R; Agou F; Smahi A
    J Allergy Clin Immunol; 2017 Dec; 140(6):1671-1682.e2. PubMed ID: 28249776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incontinentia Pigmenti.
    Cammarata-Scalisi F; Fusco F; Ursini MV
    Actas Dermosifiliogr (Engl Ed); 2019 May; 110(4):273-278. PubMed ID: 30660327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incontinentia pigmenti / Bloch-Sulzberger syndrome: a case report.
    Nirmalasari DA; Tabri F; Waspodo N; Rimayani S; Adriani A
    Acta Dermatovenerol Alp Pannonica Adriat; 2022 Mar; 31(1):39-41. PubMed ID: 35339131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incontinentia pigmenti (Bloch-Sulzberger syndrome).
    Narayanan MJ; Rangasamy S; Narayanan V
    Handb Clin Neurol; 2015; 132():271-80. PubMed ID: 26564087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease.
    Conte MI; Pescatore A; Paciolla M; Esposito E; Miano MG; Lioi MB; McAleer MA; Giardino G; Pignata C; Irvine AD; Scheuerle AE; Royer G; Hadj-Rabia S; Bodemer C; Bonnefont JP; Munnich A; Smahi A; Steffann J; Fusco F; Ursini MV
    Hum Mutat; 2014 Feb; 35(2):165-77. PubMed ID: 24339369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel inhibitor of nuclear factor kappa-B kinase subunit gamma mutation identified in an incontinentia pigmenti patient with syndromic tooth agenesis.
    Sun S; Li F; Liu Y; Qu H; Wong SW; Zeng L; Yu M; Feng H; Liu H; Han D
    Arch Oral Biol; 2019 May; 101():100-107. PubMed ID: 30913450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hypertension and vasculopathy in incontinentia pigmenti: a case report.
    Alshenqiti A; Nashabat M; AlGhoraibi H; Tamimi O; Alfadhel M
    Ther Clin Risk Manag; 2017; 13():629-634. PubMed ID: 28533687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incontinentia pigmenti (Bloch-Sulzberger syndrome) manifesting as painful periungual and subungual tumours.
    Adeniran A; Townsend PL; Peachey RD
    J Hand Surg Br; 1993 Oct; 18(5):667-9. PubMed ID: 8294840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incontinentia pigmenti.
    Motamedi MH; Lotfi A; Azizi T; Moshref M; Farhadi S
    Indian J Pathol Microbiol; 2010; 53(2):302-4. PubMed ID: 20551538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncovering incontinentia pigmenti: From DNA sequence to pathophysiology.
    How KN; Leong HJY; Pramono ZAD; Leong KF; Lai ZW; Yap WH
    Front Pediatr; 2022; 10():900606. PubMed ID: 36147820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incontinentia pigmenti: a window to the role of NF-kappaB function.
    Bruckner AL
    Semin Cutan Med Surg; 2004 Jun; 23(2):116-24. PubMed ID: 15295921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incontinentia pigmenti: treatment of IP with topical tacrolimus.
    Jessup CJ; Morgan SC; Cohen LM; Viders DE
    J Drugs Dermatol; 2009 Oct; 8(10):944-6. PubMed ID: 19852125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subungual tumors in incontinentia pigmenti.
    Simmons DA; Kegel MF; Scher RK; Hines YC
    Arch Dermatol; 1986 Dec; 122(12):1431-4. PubMed ID: 3789779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficiency and/or inflammation.
    Fusco F; Pescatore A; Conte MI; Mirabelli P; Paciolla M; Esposito E; Lioi MB; Ursini MV
    Int Rev Immunol; 2015; 34(6):445-59. PubMed ID: 26269396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology.
    Berlin AL; Paller AS; Chan LS
    J Am Acad Dermatol; 2002 Aug; 47(2):169-87; quiz 188-90. PubMed ID: 12140463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blaschko line analogies in the central nervous system: a hypothesis.
    Minić S; Trpinac D; Obradović M
    Med Hypotheses; 2013 Oct; 81(4):671-4. PubMed ID: 23932762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bloch Sulzberger syndrome (Incontinentia Pigmenti): a rare case report with dental defects.
    Shankar YU; Fatima N; Kumar MA; Prakash KS
    J Indian Soc Pedod Prev Dent; 2015; 33(1):74-7. PubMed ID: 25572380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incontinentia pigmenti (Bloch-Sulzberger syndrome): a systemic disorder.
    Ehrenreich M; Tarlow MM; Godlewska-Janusz E; Schwartz RA
    Cutis; 2007 May; 79(5):355-62. PubMed ID: 17569396
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.